News | December 23, 2022
Strides Pharma Global receives AUD 94 mn for sale of Australia's operations
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
According to IQVIA sales data for the 12-month period ending October 2022, the Cardene Capsules, 20 mg and 30 mg market achieved annual sales of approximately US $10.9 million
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Subscribe To Our Newsletter & Stay Updated
